- FDA Approval Of Gilead CAR-T Therapy Will Move The NeedleSeeking Alpha
- These 5 Top Stocks Are Moving Late On News: S&P 500 FuturesInvestor’s Business Daily
- A cancer treatment that’s part of ‘a big new field of medicine’ just got approvedBusiness Insider
- UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
- Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post